Literature DB >> 18200663

Recent trends in the surgical management of inflammatory bowel disease.

Robert E Roses1, John L Rombeau.   

Abstract

Surgery is required in the vast majority of patients with Crohn's disease (CD) and in approximately one-third of patients with ulcerative colitis (UC). Similar to medical treatments for IBD, significant advances have occurred in surgery. Advances in CD include an emphasis upon conservatism as exemplified by more limited resections, strictureplasties, and laparoscopic resections. The use of probiotics in selected patients has improved the outcome in patients with pouchitis following restorative proctocolectomy for UC. It is anticipated that ongoing discoveries in the molecular basis of IBD will in turn identify those patients who will best respond to surgery.

Entities:  

Mesh:

Year:  2008        PMID: 18200663      PMCID: PMC2679129          DOI: 10.3748/wjg.14.408

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  18 in total

1.  Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial.

Authors:  P Gionchetti; F Rizzello; A Venturi; P Brigidi; D Matteuzzi; G Bazzocchi; G Poggioli; M Miglioli; M Campieri
Journal:  Gastroenterology       Date:  2000-08       Impact factor: 22.682

Review 2.  The surgical management of Crohn's disease.

Authors:  W H Schraut
Journal:  Gastroenterol Clin North Am       Date:  2002-03       Impact factor: 3.806

Review 3.  Surgery for ulcerative colitis.

Authors:  David Blumberg; David E Beck
Journal:  Gastroenterol Clin North Am       Date:  2002-03       Impact factor: 3.806

Review 4.  Perianal Crohn's disease.

Authors:  B Singh; N J McC Mortensen; D P Jewell; B George
Journal:  Br J Surg       Date:  2004-07       Impact factor: 6.939

5.  Laparoscopic-assisted versus open ileocolic resection for Crohn's disease: a randomized trial.

Authors:  Stefan Maartense; Mich S Dunker; J Frederik M Slors; Miguel A Cuesta; Erik G J M Pierik; Dirk J Gouma; Daan W Hommes; Miriam A Sprangers; Willem A Bemelman
Journal:  Ann Surg       Date:  2006-02       Impact factor: 12.969

6.  Wide-lumen stapled anastomosis vs. conventional end-to-end anastomosis in the treatment of Crohn's disease.

Authors:  M Muñoz-Juárez; T Yamamoto; B G Wolff; M R Keighley
Journal:  Dis Colon Rectum       Date:  2001-01       Impact factor: 4.585

7.  Combined seton placement, infliximab infusion, and maintenance immunosuppressives improve healing rate in fistulizing anorectal Crohn's disease: a single center experience.

Authors:  Dawnelle R Topstad; Remo Panaccione; John A Heine; Douglas R E Johnson; Anthony R MacLean; W Donald Buie
Journal:  Dis Colon Rectum       Date:  2003-05       Impact factor: 4.585

8.  Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis.

Authors:  T Mimura; F Rizzello; U Helwig; G Poggioli; S Schreiber; I C Talbot; R J Nicholls; P Gionchetti; M Campieri; M A Kamm
Journal:  Gut       Date:  2004-01       Impact factor: 23.059

9.  Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial.

Authors:  Paolo Gionchetti; Fernando Rizzello; Ulf Helwig; Alessandro Venturi; Karen Manon Lammers; Patrizia Brigidi; Beatrice Vitali; Gilberto Poggioli; Mario Miglioli; Massimo Campieri
Journal:  Gastroenterology       Date:  2003-05       Impact factor: 22.682

10.  Treatment of perianal fistulizing Crohn's disease with infliximab alone or as an adjunct to exam under anesthesia with seton placement.

Authors:  Miguel Regueiro; Houssam Mardini
Journal:  Inflamm Bowel Dis       Date:  2003-03       Impact factor: 5.325

View more
  7 in total

1.  Progress in the diagnosis and treatment of inflammatory bowel disease.

Authors:  Edward V Loftus
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-02

2.  Obesity Does Not Impact Perioperative or Postoperative Outcomes in Patients with Inflammatory Bowel Disease.

Authors:  Jesse Guardado; Evie Carchman; Ashley E Danicic; Javier Salgado; Andrew R Watson; James P Celebrezze; David S Medich; Jennifer Holder-Murray
Journal:  J Gastrointest Surg       Date:  2015-12-22       Impact factor: 3.452

Review 3.  Postsurgical recurrence of ileal Crohn's disease: an update on risk factors and intervention points to a central role for impaired host-microflora homeostasis.

Authors:  Michael F Cunningham; Neil G Docherty; J Calvin Coffey; John P Burke; P Ronan O'Connell
Journal:  World J Surg       Date:  2010-07       Impact factor: 3.352

4.  A contemporary series of surgical outcomes following subtotal colectomy and/or completion proctectomy for management of inflammatory bowel disease.

Authors:  Lucy Burns; Michael E Kelly; Maria Whelan; James O'Riordan; Paul Neary; Dara O Kavanagh
Journal:  Ir J Med Sci       Date:  2022-01-17       Impact factor: 1.568

5.  What's new in inflammatory bowel disease in 2008?

Authors:  Daniel C Baumgart
Journal:  World J Gastroenterol       Date:  2008-01-21       Impact factor: 5.742

6.  An anti-inflammatory diet as treatment for inflammatory bowel disease: a case series report.

Authors:  Barbara C Olendzki; Taryn D Silverstein; Gioia M Persuitte; Yunsheng Ma; Katherine R Baldwin; David Cave
Journal:  Nutr J       Date:  2014-01-16       Impact factor: 3.271

7.  Gastrocolic fistula in Crohn's disease detected by oral agent contrast-enhanced ultrasound: A case report of a novel ultrasound modality.

Authors:  Shuang Wu; Hua Zhuang; Jie-Ying Zhao; Yu-Fang Wang
Journal:  World J Gastroenterol       Date:  2020-05-07       Impact factor: 5.742

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.